REQUEST A DEMO
Total
USD $0.00
Search more companies

Jw Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Jw Pharmaceutical Co.,Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

JW Pharmaceutical Corporation operates in the pharmaceutical industry, focusing on the research, development, and manufacturing of medicines. The company's product offerings include therapeutic drugs for cardiovascular, metabolic, and rare diseases, as well as healthcare products like wound care solutions and infusion therapies. The company's estimated revenue is around $1 billion.

Headquarters
2477 Nambusunhwan-Ro, Seocho-Gu
Seoul; Seoul;

Contact Details: Purchase the Jw Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.jw-pharma.co.kr

Basic Information
Total Employees:
Purchase the Jw Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Jw Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Jw Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Jw Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
August 08, 1945
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
48.45%
Purchase this report to view the information.
0.69%
Purchase this report to view the information.
0.12%
Purchase this report to view the information.
0.07%
Purchase this report to view the information.
0.07%
Subsidiaries
Jw Theriac Pharmaceutical Corporation
100%
(주)C C신약연구소
50%
Jw이노스퀘어Pfv
47.4%
Company Performance
Financial values in the chart are available after Jw Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.43%
Total operating revenue
8.48%
Operating Profit/Loss (EBIT)
7.72%
EBITDA
22.04%
Net Profit/Loss for the Period
-4.65%
Total Assets
-3.98%
Total Equity
16.57%
Operating Profit Margin (ROS)
-0.08%
Net Profit Margin
-1.09%
Return on Equity (ROE)
-2.91%
Debt/Equity
-25.05%
Quick Ratio
0.02%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?